tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports
Want to see MBRX full AI Analyst Report?

Moleculin Biotech (MBRX) Income Statement

1,938 Followers

Moleculin Biotech Income Statement

Last quarter (Q4 2025), Moleculin Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Moleculin Biotech's net income was $15.55M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -90.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 25.10M$ 26.64M$ 29.63M$ 30.64M$ 22.97M
Depreciation and Amortization
$ 90.00K$ 126.00K$ 127.00K$ 130.00K$ 164.00K
EBITDA
$ -25.01M$ -26.52M$ -29.50M$ -30.51M$ -22.80M
Operating Income
$ -25.10M$ -26.64M$ -29.63M$ -30.64M$ -22.97M
Other Income/Expenses
$ -8.46M$ 4.88M$ -138.00K$ 1.61M$ 7.07M
Pretax Income
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Net Income
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Per Share Metrics
Basic EPS
$ -28.42$ -158.00$ -376.75$ -380.50$ -221.75
Diluted EPS
$ -28.42$ -158.00$ -376.75$ -380.50$ -221.75
Weighted Average Shares Outstanding
 11.85M 137.72K 79.02K 76.28K 71.67K
Weighted Average Shares Outstanding (Diluted)
 11.85M 137.72K 79.02K 76.28K 71.67K
Currency in USD

Moleculin Biotech Earnings and Revenue History